9.850USD+0.72%Mkt Cap: 958.82M $P/E: —1d ago
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel …
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/B
Avg
1M Perf
Lower
$140.84BUSDP/E 48.3
$82.06BUSDP/E 32.9
$70.27BUSDP/E 34.6
$41.70BUSDP/E 26.4
$30.39BUSDP/E 40.4
$28.27BUSDP/E 18.8
$25.36BUSDP/E 48.0
$19.36BUSDP/E 47.7
$19.20BUSDP/E 65.8
$17.23BUSDP/E 97.7
$14.10BUSDP/E 79.9
$13.99BUSDP/E 60.8
$13.36BUSDP/E 9.4
$12.22BUSDP/E 39.9
$12.08BUSDP/E 28.3
$11.01BUSD
$7.99BUSDP/E 21.4
$7.70BUSDP/E 151.6
$6.76BUSD
$5.47BUSDP/E 22.4
$5.61BUSDP/E 2112.7
$4.57BUSDP/E 30.7
$4.29BUSDP/E 64.3
$4.20BUSD
$4.14BUSDP/E 29.9
$3.91BUSDP/E 17.5
$3.53BUSDP/E 35.5
$3.72BUSDP/E 3034.0
$3.66BUSDP/E 78.8
$2.83BUSDP/E 18.2
$2.53BUSDP/E 19.4
$2.34BUSD
$2.19BUSDP/E 35.3
$2.13BUSD
$1.90BUSDP/E 35.1
$1.92BUSD
$1.49BUSD
$1.32BUSDP/E 76.6
$1.43BUSD
$1.42BUSD
$1.38BUSD
$1.18BUSD
$1.04BUSDP/E 40.9
$734.26MUSDP/E 15.6
$730.84MUSDP/E 14.3
$661.20MUSDP/E 56.0
$590.13MUSDP/E 34.6
$537.56MUSD
$353.32MUSDP/E 17.0
$349.17MUSDP/E 20.5
$307.06MUSD
$245.96MUSDP/E 13.6
$222.60MUSDP/E 37.5
$208.68MUSDP/E 25.0
$219.63MUSDP/E 20.4
$216.18MUSDP/E 393.2
$193.41MUSDP/E 1.7
$192.92MUSD
$186.94MUSDP/E 16.1
$164.23MUSD
$168.11MUSD
$130.97MUSD
$115.74MUSD
$115.11MUSD
$113.02MUSDP/E 35.9
$60.10MUSDP/E 6.3
$59.94MUSD
$55.82MUSD
$42.24MUSDP/E 42.0
$38.76MUSDP/E 51.0
$31.09MUSD
$28.39MUSD
$27.74MUSD
$21.55MUSD
$23.39MUSDP/E 163.0
$16.19MUSD
$15.09MUSD
$14.74MUSD
$12.97MUSD
$12.62MUSD
$7.73MUSDP/E 13.3
$4.91MUSD
$4.99MUSD
$4.62MUSD
$465.9KUSD
$126.1KUSD
Indicators:|
Key Statistics
Company
Market Cap958.82M $
Enterprise Value679.82M $
Revenue (TTM)1.85M $
Gross Profit1.38M $
Net Income (TTM)-95.30M $
Revenue/Share0.0380 USD
Last Price9.850 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees174
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.05
PEG—
EV/EBITDA-7.20
EV/Revenue367.27
P/S518.00
P/B3.44
EPS (TTM)-2.22
EPS (Forward)-0.98
52W Range
2.85091% of range10.56
52W High10.56 USD
52W Low2.850 USD
Profitability
Gross Margin74.28%
Oper. Margin-4859.72%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-59.21%
ROA-33.99%
Growth
Revenue Growth-11.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-34.63M $
CapEx (TTM)2.39M $
FCF Margin-2844.73%
FCF Yield-5.49%
Net Debt-278.96M $
Net Debt/EBITDA2.95
Balance Sheet
Debt/Equity0.09
Current Ratio20.93
Quick Ratio20.66
Book Value/Sh2.864 USD
Cash/Share2.904 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.33 USD
Upside (mean)+55.7%
Target Range15.00 USD – 16.00 USD
$15.00+55.7% to mean$16.00
# Analysts3
Ownership
Shares Out.97.34M
Float60.31M
Insiders16.49%
Institutions66.10%
Short Interest
Short Ratio4.2d
Short % Float8.34%
Short % Out.5.83%
Shares Short5.68M
Short (prev mo.)4.19M
Technical
SMA 507.982 (+23.4%)
SMA 2005.878 (+67.6%)
Beta0.73
S&P 52W Chg20.05%
Avg Vol (30d)1.27M
Avg Vol (10d)1.63M
Technical Indicators
RSI (14)59.7
MACD0.4816
MACD Signal0.5573
MACD Hist.-0.0757
BB Upper10.29 USD
BB Middle9.588 USD
BB Lower8.884 USD
BB Width14.68%
ATR (14)0.5936 USD
Vol Ratio (20d)1.29x